{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:16:42Z","timestamp":1788470202171,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20240813111059001"],"award-info":[{"award-number":["JCYJ20240813111059001"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32470836"],"award-info":[{"award-number":["32470836"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372854"],"award-info":[{"award-number":["82372854"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042022rc0024"],"award-info":[{"award-number":["2042022rc0024"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016359","name":"Zhongnan Hospital of Wuhan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jbc.2025.110918","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T01:23:04Z","timestamp":1763083384000},"page":"110918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["RhoE downregulation leads to enhanced cholesterol biosynthesis and sorafenib resistance in hepatocellular carcinoma"],"prefix":"10.1016","volume":"301","author":[{"given":"Jingxiu","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110918_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbc.2025.110918_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jbc.2025.110918_bib3","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jbc.2025.110918_bib4","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2025.110918_bib5","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2025.110918_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL clinical practice guidelines on the management of hepatocellular carcinoma","volume":"82","author":"European Assoc Study","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jbc.2025.110918_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduction Targeted Ther."},{"key":"10.1016\/j.jbc.2025.110918_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13046-019-1265-1","article-title":"The roles of nuclear focal adhesion kinase (FAK) on cancer: a focused review","volume":"38","author":"Zhou","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2025.110918_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pharmthera.2014.10.001","article-title":"FAK signaling in human cancer as a target for therapeutics","volume":"146","author":"Lee","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2025.110918_bib10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrc3792","article-title":"FAK in cancer: mechanistic findings and clinical applications","volume":"14","author":"Sulzmaier","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2025.110918_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2004.03.029","article-title":"Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor","volume":"41","author":"Fujii","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jbc.2025.110918_bib12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/cdd.2017.34","article-title":"Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2","volume":"24","author":"Gnani","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbc.2025.110918_bib13","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.30707","article-title":"Focal adhesion kinase and \u03b2-Catenin cooperate to induce hepatocellular carcinoma","volume":"70","author":"Shang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2025.110918_bib14","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/annonc\/mdw427","article-title":"A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors","volume":"27","author":"Soria","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbc.2025.110918_bib15","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00280-016-3010-1","article-title":"A first-in-asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors","volume":"77","author":"Shimizu","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jbc.2025.110918_bib16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s10637-015-0282-y","article-title":"A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors","volume":"33","author":"Jones","year":"2015","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.jbc.2025.110918_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.lungcan.2019.10.033","article-title":"Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer (vol 139, pg 60, 2020)","volume":"139","author":"Gerber","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jbc.2025.110918_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41568-021-00340-6","article-title":"Targeting FAK in anticancer combination therapies","volume":"21","author":"Dawson","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2025.110918_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113116","article-title":"Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment","volume":"151","author":"Wu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jbc.2025.110918_bib20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1200\/JCO.2018.79.0543","article-title":"Maintenance defactinib versus placebo after first-line chemotherapy in patients with merlin-stratified pleural mesothelioma: COMMAND-A double-blind, randomized, phase II study","volume":"37","author":"Fennell","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbc.2025.110918_bib21","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1200\/JCO.21.02371","article-title":"Alliance A071401: phase II trial of focal adhesion kinase inhibition in Meningiomas with somatic NF2 mutations","volume":"41","author":"Brastianos","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbc.2025.110918_bib22","doi-asserted-by":"crossref","first-page":"9071","DOI":"10.1200\/JCO.2022.40.16_suppl.9071","article-title":"First-In-Human Phase I Results of APG-2449, a Novel FAK and third-generation ALK\/ROS1 Tyrosine Kinase Inhibitor (TKI), in Patients (Pts) with second-generation TKI-resistant ALK\/ROS1+ Non-small Cell Lung Cancer (NSCLC) or Mesothelioma","volume":"40","author":"Zhao","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jbc.2025.110918_bib23","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/gutjnl-2018-316408","article-title":"Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial","volume":"68","author":"Pinyol","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jbc.2025.110918_bib24","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/jhep.2003.50457","article-title":"PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas","volume":"38","author":"Okamoto","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2025.110918_bib25","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1101\/gr.154492.113","article-title":"Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma","volume":"23","author":"Kan","year":"2013","journal-title":"Genome Res."},{"key":"10.1016\/j.jbc.2025.110918_bib26","doi-asserted-by":"crossref","first-page":"H1488","DOI":"10.1152\/ajpheart.00692.2004","article-title":"RhoA\/ROCK signaling is critical to FAK activation by cyclic stretch in cardiac myocytes","volume":"289","author":"Torsoni","year":"2005","journal-title":"Am. J. Physiol Heart Circulatory Physiol."},{"key":"10.1016\/j.jbc.2025.110918_bib27","article-title":"High-throughput chemogenetic drug screening reveals PKC-RhoA\/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma","volume":"4","author":"Arang","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jbc.2025.110918_bib28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/2159-8290.CD-19-0811","article-title":"Gain-of-Function RHOA mutations promote focal adhesion kinase activation and dependency in diffuse","volume":"10","author":"Zhang","year":"2020","journal-title":"Gastric Cancer Cancer Discov."},{"key":"10.1016\/j.jbc.2025.110918_bib29","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccell.2025.02.001","article-title":"FAK Inhibition Combined with the RAF-MEK Clamp Avutometinib Overcomes Resistance to Targeted and Immune Therapies in BRAF V600E Melanoma","volume":"43","author":"Lubrano","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2025.110918_bib30","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1158\/0008-5472.CAN-21-2934","article-title":"Caspase-3-Induced activation of SREBP2 drives drug resistance via promotion of cholesterol biosynthesis in hepatocellular carcinoma","volume":"82","author":"Mok","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2025.110918_bib31","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.chom.2024.07.012","article-title":"BCAA-producing Clostridium symbiosum promotes colorectal tumorigenesis through the modulation of host cholesterol metabolism cell","volume":"32","author":"Ren","year":"2024","journal-title":"Host Microbe"},{"key":"10.1016\/j.jbc.2025.110918_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm5563","article-title":"Patched 1 regulates smoothened by controlling sterol binding to its extracellular cysteine-rich domain","volume":"8","author":"Kinnebrew","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2025.110918_bib33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.bbamcr.2011.09.017","article-title":"Akt acutely activates the cholesterogenic transcription factor SREBP-2","volume":"1823","author":"Luu","year":"2012","journal-title":"Biochim. Biophys. Acta Molecular Cell Res."},{"key":"10.1016\/j.jbc.2025.110918_bib34","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s12276-023-01079-w","article-title":"Functional significance of cholesterol metabolism in cancer: from threat to treatment","volume":"55","author":"Xiao","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jbc.2025.110918_bib35","first-page":"9377","article-title":"Inhibition of the PI3K\/Akt signaling pathway reverses sorafenib-derived chemo-resistance in hepatocellular carcinoma","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jbc.2025.110918_bib36","first-page":"4951","article-title":"PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras\/Raf\/MAPK and PI3K\/AKT\/mTOR pathways","volume":"30","author":"Gedaly","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jbc.2025.110918_bib37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/hep.27402","article-title":"FAK is required for c-Met\/\u03b2-Catenin-Driven","volume":"61","author":"Shang","year":"2015","journal-title":"Hepatocarcinogenesis Hepatol."},{"key":"10.1016\/j.jbc.2025.110918_bib38","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1038\/s41467-022-33493-5","article-title":"Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK","volume":"13","author":"Ge","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110918_bib39","first-page":"994","article-title":"BARMR1 -mediated sorafenib resistance is derived through stem-like property acquisition by activating integrin-FAK signaling pathways","volume":"5","year":"2020","journal-title":"Signal Transduction Targeted Ther."},{"key":"10.1016\/j.jbc.2025.110918_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.molcel.2009.06.013","article-title":"FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST","volume":"35","author":"Zheng","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2025.110918_bib41","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1158\/1535-7163.MCT-17-0561","article-title":"Wnt\/\u03b2-Catenin pathway activation mediates adaptive resistance to BRAF inhibition in colorectal","volume":"17","author":"Chen","year":"2018","journal-title":"Cancer Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2025.110918_bib42","doi-asserted-by":"crossref","first-page":"905","DOI":"10.15252\/msb.20166796","article-title":"Adaptive Resistance of Melanoma Cells to RAF Inhibition via Reversible Induction of a Slowly Dividing de-differentiated State","volume":"13","author":"Fallahi-Sichani","year":"2017","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.jbc.2025.110918_bib43","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jhep.2020.08.036","article-title":"RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma","volume":"74","author":"Chan","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jbc.2025.110918_bib44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13046-022-02306-4","article-title":"Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma","volume":"41","author":"Li","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2025.110918_bib45","article-title":"CSN6-SPOP-HMGCS1 axis promotes hepatocellular carcinoma progression via YAP1 activation","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jbc.2025.110918_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.jbc.2025.110918_bib47","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2025.110918_bib48","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110918_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development","volume":"9","author":"Finan","year":"2017","journal-title":"Sci. Transl Med."},{"key":"10.1016\/j.jbc.2025.110918_bib50","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"10.1016\/j.jbc.2025.110918_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/nature20580","article-title":"Drug response consistency in CCLE and CGP","volume":"540","author":"Bouhaddou","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110918_bib52","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582502770X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582502770X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:21:39Z","timestamp":1773872499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582502770X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S002192582502770X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110918","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RhoE downregulation leads to enhanced cholesterol biosynthesis and sorafenib resistance in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110918"}}